Inhibition of hepatitis C virus protein expression by RNA interference

Virus Research

Volumn 96, Issue 1-2, 2003, Pages 27-35

  Sen, Adrish ^a   Steele, Robert ^a   Ghosh, Asish K ^a   Basu, Arnab ^a   Ray, Ranjit ^a   Ray, Ratna B ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

HCV; NS5A protein; RNA interference

Indexed keywords

ALPHA ACTIN; COMPLEMENTARY DNA; CORE PROTEIN; DOUBLE STRANDED RNA; GENE PRODUCT; INTERLEUKIN 8; PROTEIN SERINE THREONINE KINASE; VIRUS PROTEIN; VIRUS RNA;

ARTICLE; CONTROLLED STUDY; GENE ACTIVATION; GENE SILENCING; GENOTYPE; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; MOLECULAR CLONING; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION;

HEPATITIS C VIRUS;

EID: 0142091755     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-1702(03)00170-9     Document Type: Article

References (64)

1. Alter, H.J., Seeff, L.B., 2000. Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long-term outcome. Semin. Liver Dis. 20, 17-35.
2. Bartenschlager R. In vitro models for hepatitis C. Virus Res. 82:2002;25-32.
3. Bitko V., Barik S. Phenotypic silencing of cytoplasmic genes using sequence-specific double-stranded short interfering RNA and its application in the reverse genetics of wild type negative-strand RNA viruses. BMC Microbiol. 1:2001;34.
4. Blight K.J., Kolykhalov A.A., Rice C.M. Efficient initiation of HCV RNA replication in cell culture. Science. 290:2000;1972-1974.
5. Brummelkamp T.R., Bernards R., Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science. 296:2002;550-553.
6. Castet V., Fournier C., Soulier A., Brillet R., Coste J., Larrey D., Dhumeaux D., Maurel P., Pawlotsky J.M. Alpha interferon inhibits hepatitis C virus replication in primary human hepatocytes infected in vitro. J. Virol. 76:2002;8189-8199.
7. Choo Q.L., Kuo G., Weiner A.J., Overby L.R., Bradley D.W., Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science. 244:1989;359-362.
8. Coburn G.A., Cullen B.R. Potent and specific inhibition of human immunodeficiency virus type I replication by RNA interference. J. Virol. 76:2002;9225-9231.
9. Di Bisceglie A.M., Carithers R.L., Gores G.J. Hepatocellular carcinoma. Hepatology. 28:1998;1161-1165.
10. Elbashir S.M., Harborth J., Lendeckel W., Yalcin A., Weber K., Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature. 411:2001;494-498.
11. Enomoto N., Sakuma I., Asahina Y., Kurosaki M., Murakami T., Yamamoto C., Izumi N., Marumo F., Sato C. Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region. J. Clin. Invest. 96:1995;224-230.
12. Enomoto N., Sakuma I., Asahina Y., Kurosaki M., Murakami T., Yamamoto C., Ogura Y., Izumi N., Marumo F., Sato C. Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection. N. Engl. J. Med. 334:1996;77-81.
13. Farci P., Alter H.J., Govindarajan S., Wong D.C., Engle R., Lesniewski R.R., Mushahwar I.K., Desai S.M., Miller R.H., Ogata N., Purcell R.H. Lack of protective immunity against reinfection with hepatitis C virus. Science. 258:1992;135-140.
14. Ghosh A.K., Majumder M., Steele R., Meyer K., Ray R., Ray R.B. Hepatitis C virus NS5A protein protects against TNF-alpha mediated apoptotic cell death. Virus Res. 67:2000;173-178.
15. Ghosh A.K., Majumder M., Steele R., Meyer K., Ray R., Ray R.B. Modulation of interferon expression by hepatitis C virus NS5A protein and human homeodomain protein PTX1. Virology. 306:2003;51-59.
16. Gitlin L., Karelsky S., Andino R. Short interfering RNA confers intracellular antiviral immunity in human cells. Nature. 418:2002;430-434.
17. Grakoui A., Wychowski C., Lin C., Feinstone S.M., Rice C.M. Expression and identification of hepatitis C virus polyprotein cleavage products. J. Virol. 67:1993;1385-1395.
18. Hayashi J., Aoki H., Arakawa Y., Hino O. Hepatitis C virus and hepatocarcinogenesis. Intervirology. 42:1999;205-210.
19. Hijikata M., Kato N., Ootsuyama Y., Nakagawa M., Shimotohno K. Gene mapping of the putative structural region of the hepatitis C virus genome by in vitro processing analysis. Proc. Natl. Acad. Sci. USA. 88:1991;5547-5551.
20. Hoofragle, J.H., Di Bisceglie, A.M., 1997. The treatment of chronic viral hapatitis. N. Engl. J. Med. 336, 347-356.
21. Hoofragle, J.H., Di Bisceglie, A.M., 1997. The treatment of chronic viral hapatitis. N. Engl. J. Med. 336, 347-356.
22. Jaeckel, E., Cornberg, M., Wedemeyer, H., Santantonio, T., Mayer, J., Zankel, M., Pasture, G., Dietrich, M., Trantwein, C., Manns, M.P., 2001. Treatment of acute hepatitis C with interferon α-2b. N. Engl. J. Med. 345, 1452-1457.
23. Jaeckel, E., Cornberg, M., Wedemeyer, H., Santantonio, T., Mayer, J., Zankel, M., Pasture, G., Dietrich, M., Trantwein, C., Manns, M.P., 2001. Treatment of acute hepatitis C with interferon α-2b. N. Engl. J. Med. 345, 1452-1457.
24. Jia Q., Sun R. Inhibition of gammaherpesvirus replication by RNA interference. J. Virol. 77:2003;3301-3306.
25. Kaito M., Watanabe S., Tsukiyama-Kohara K., Yamaguchi K., Kobayashi Y., Konishi M., Yokoi M., Ishida S., Suzuki S., Kohara M. Hepatitis C virus particle detected by immunoelectron microscopic study. J. Gen. Virol. 75:1994;1755-1760.
26. Kaneko T., Tanji Y., Satoh S., Hijikata M., Asabe S., Kimura K., Shimitono K. Production of two phosphoproteins from the NS5A region of the hepatitis C viral genome. Biochem. Biophys. Res. Commun. 205:1994;320-326.
27. Kapadia S.B., Brideau-Andersen A., Chisari F.V. Interference of hepatitis C virus RNA replication by short interfering RNAs. Proc. Natl. Acad. Sci. USA. 100:2003;2014-2018.
28. Kato N., Yokosuka O., Hosoda K., Ito Y.M., Ohto M., Omata M. Quantification of hepatitis C virus by competitive reverse transcription- polymerase chain reaction: increase of the virus in advanced liver disease. Hepatology. 18:1993;16-20.
29. Kolykhalov A.A., Agapov E.V., Bright K.J., Mihalik K., Feinstone S.M., Rice C.M. Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA. Science. 277:1997;570-574.
30. Koziel M.J. Cytokines in viral hepatitis. Semin. Liver Dis. 19:1999;157-169.
31. Kumar M., Carmichael G.G. Antisense RNA: function and fate of duplex RNA in cells of higher eukaryotes. Microbiol. Mol. Biol. Rev. 62:1998;1415-1434.
32. Lee N.S., Dohjima T., Bauer G., Li H., Li M.J., Ehsani A., Salvaterra P., Rossi J. Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells. Nat. Biotechnol. 20:2002;500-505.
33. Lindenbach B.D., Rice C.M. RNAi targeting an animal virus: news from the front. Mol. Cell. 9:2002;925-927.
34. Majumder M., Ghosh A.K., Steele R., Ray R., Ray R.B. Hepatitis C virus NS5A physically associates with p53 and regulates p21/waf1 gene expression in p53-dependent manner. J. Virol. 75:2001;1401-1407.
35. Majumder M., Ghosh A.K., Steele R., Zhou X.Y., Phillips N.J., Ray R., Ray R.B. Hepatitis C virus NS5A protein impairs TNF mediated hepatic apoptosis, but not by an anti-Fas antibody, in transgenic mice. Virology. 294:2002;94-105.
36. McCaffrey A.P., Meuse L., Pham T.T., Conklin D.S., Hannon G.J., Kay M.A. RNA interference in adult mice. Nature. 418:2002;38-39.
37. McHutchison, J.G., Gordon, S.C., Schiff, E.R., Shiffman, M.L., Lee, W.M., Rustgi, V.K., Goodman, Z.D., Ling, M.H., Cort, S., Albrecht, J.K., 1998. Interferon α-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. N. Engl. J. Med. 339, 1485-1492.
38. Moradpour, D., Blum, H.E., 1999. Current and evolving therapies for hepatitis C. Eur. J. Gastroenterol. Hepatol. 11, 1199-1202.
39. Moradpour, D., Blum, H.E., 1999. Current and evolving therapies for hepatitis C. Eur. J. Gastroenterol. Hepatol. 11, 1199-1202.
40. Novina C.D., Murray M.F., Dykxhoorn D.M., Beresford P.J., Riess J., Lee S.K., Collman R.G., Lieberman J., Shankar P., Sharp P.A. siRNA-directed inhibition of HIV-1 infection. Nat. Med. 8:2002;681-686.
41. Pietschmann T., Lohmann V., Kaul A., Krieger N., Rinck G., Rutter G., Strand D., Bartenschlager R. Persistent and transient replication of full-length hepatitis C virus genomes in cell culture. J. Virol. 76:2002;4008-4021.
42. Polyak S.J., McArdle S., Liu S.L., Sullivan D.G., Chung M., Hofgartner W.T., Carithers R.L. Jr., McMahon B.J., Mullins J.I., Corey L., Gretch D.R. Evolution of hepatitis C virus quasispecies in hypervariable region 1 and the putative interferon sensitivity-determining region during interferon therapy and natural infection. J. Virol. 72:1998;4288-4296.
43. Polyak S.J., Khabar K.S., Paschal D.M., Ezelle H.J., Duverlie G., Barber G.N., Levy D.E., Mukaida N., Gretch D.R. Hepatitis C virus nonstructural 5A protein induces interleukin-8, leading to partial inhibition of the interferon-induced antiviral response. J. Virol. 75:2001;6095-6106.
44. Poynard, T., Leroy, V., Cohard, M., Thevenot, T., Mathurin, P., Opolon, P., Zarski, J.P., 1996. Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: effects of dose and duration. Hepatology 24, 778-789.
45. Poynard, T., Leroy, V., Cohard, M., Thevenot, T., Mathurin, P., Opolon, P., Zarski, J.P., 1996. Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: effects of dose and duration. Hepatology 24, 778-789.
46. Randall G., Grakoui A., Rice C.M. Clearance of replicating hepatitis C virus replicon RNAs in cell culture by small interfering RNAs. Proc. Natl. Acad. Sci. USA. 100:2003;235-240.
47. Ray R., Meyer K., Newman F.K., Belshe R.B. Characterization of a live, attenuated human parainfluenza type 3 virus candidate vaccine strain. J. Virol. 69:1995;1959-1963.
48. Reed K.E., Xu J., Rice C.M. Phosphorylation of the hepatitis C virus NS5A protein in vitro and in vivo: properties of the NS5A-associated kinase. J. Virol. 71:1997;7187-7197.
49. Rehermann B., Chisari F.V. Cell mediated immune response to the hepatitis C virus. Curr. Top Microbiol. Immunol. 242:2000;299-325.
50. Rosen H.R., Ribeiro R.R., Weinberger L., Wolf S., Chung M., Gretch D.R., Perelson A.S. Early hepatitis C viral kinetics correlate with long-term outcome in patients receiving high dose induction followed by combination interferon and ribavirin therapy. J. Hepatol. 37:2002;124-130.
51. Saito I., Miyamura T., Ohbayashi A., Harada H., Katayama T., Kikuchi S., Watanabe Y., Koi S., Onji M., Choo Q.-L., Houghton M., Kuo G. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc. Natl. Acad. Sci. USA. 87:1990;6547-6549.
52. Schiappa D.A., Mittal C., Brown J.A., Mika B.P. Relationship of hepatitis C genotype 1 NS5A sequence mutations to early phase viral kinetics and interferon effectiveness. J. Infect. Dis. 185:2002;868-877.
53. Sen G.C. Viruses and interferons. Annu. Rev. Microbiol. 55:2001;255-281.
54. Seo M.Y., Abrignani S., Houghton M., Han J.H. Small interfering RNA-mediated inhibition of hepatitis C virus replication in the human hepatoma cell line Huh-7. J. Virol. 77:2003;810-812.
55. Sharp P.A. RNA interference - 2001. Genes Dev. 15:2001;485-490.
56. Stark G.R., Kerr I.M., Williams B.R., Silverman R.H., Schreiber R.D. How cells respond to interferons. Annu. Rev. Biochem. 67:1998;227-264.
57. Surabhi R.M., Gaynor R.B. RNA interference directed against viral and cellular targets inhibits human immunodeficiency virus type I replication. J. Virol. 76:2002;12963-12973.
58. Tanji Y., Kaneko T., Satoh S., Shimotohno K. Phosphorylation of hepatitis C virus-encoded nonstructural protein NS5A. J. Virol. 69:1995;3980-3986.
59. Tan S.L., Katze M.G. How hepatitis C virus counteracts the interferon response: the jury is still out on NS5A. Virology. 284:2001;1-12.
60. Weiner A.J., Geysen H.M., Christopherson C., Hall J.E., Mason T.J., Saracco G., Bonino F., Crawford K., Marion C.D., Crawford K.A., et al. Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections. Proc. Natl. Acad. Sci. USA. 89:1992;3468-3472.
61. Wilson J.A., Jayasena S., Khvorova A., Sabatinos S., Rodrigue-Gervais I.G., Arya S., Sarangi F., Harris-Brandts M., Beaulieu S., Richardson C.D. RNA interference blocks gene expression and RNA synthesis from hepatitis C replicons propagated in human liver cells. Proc. Natl. Acad. Sci. USA. 100:2003;2783-2788.
62. Xia H., Mao Q., Paulson H.L., Davidson B.L. siRNA-mediated gene silencing in vitro and in vivo. Nat. Biotechnol. 20:2002;1006-1010.
63. Yanagi M., Purcell R.H., Emerson S.U., Bukh J. Transcripts from a single full-length cDNA clone of hepatitis C virus are infectious when directly transfected into the liver of a chimpanzee. Proc. Natl. Acad. Sci. USA. 94:1997;8738-8743.
64. Zamore P.D. RNA interference: listening to the sound of silence. Nat. Struct. Biol. 8:2001;746-750.